This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.
In this episode, we sit down with Sara Schweitzer , a passionate recruiter in Stryker’s spine division, whose journey into medical sales and recruiting is anything but ordinary. In this podcast, I interview top medical sales reps and leading medical sales executives across the entire world. Climb the corporate ladder.
Over the past decade, the role of Medical Affairs has expanded to impact the entire drug development continuum—from assessing unmet needs to drive early clinical development to communicating scientific data to key stakeholders to managing assets across pre-, peri-, and post-launch portfolio expansion efforts.
Stéphan Toupin, a standout in the medical sales industry, unveils his journey from academia to entrepreneurship, offering listeners an insider perspective on navigating career shifts with purpose and passion. market with foreign medical devices, detailing the essential steps companies often overlook. Moved down to the USA in 2015.
Medical Sales Reps have been on the scene since the year dot. The post Can MedicalScience Liaisons Improve Pharma Sales Effectiveness? appeared first on REVO.
AI was novel in pharma training in early 2024. For training leaders trying to cut through the noise, here are the five biggest trends shaping AI in pharma sales training in 2025. The hub benefits sales and enhances alignment with marketing and the medical team. In 2025, its everywhere.
While the sales force is still a crucial part of any pharmaceutical company, the demand for Medical Affairs teams continue to rise. How are sales reps and MedicalScience Liaisons (MSLs) the same? Ways Pharma reps and MSLs are different: Typically, an MSL holds a doctorate degree, whether it be a PhD, MD, or PharmD.
Medical communications are in a state of transition. Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content. The post Every scientific message has a story.
The number one need for physicians in most specialty groups at the diagnostic stage is medical information—scientific information meant to educate physicians on treatments and diseases—often to overcome challenges with differential diagnosis or symptom recognition. Life sciences companies’ owned channels remain relevant. Among all U.S.
Disease Prognosis and Prevention AI will help in the early detection of diseases by analyzing huge volumes of data, such as medical records, genomic data and data from mobile devices. This will lead to treatments that are more effective and safer, as the specificities of each patient will be taken into account. appeared first on MaBiCo.
As medical treatments become more complex, the role of the MedicalScience Liaison (MSL) has never been more important. Louise Picken , EVP Head of Medical Services, Complete HealthVizion. She brings over 20 years of experience in medical communications and medical training. About the panel.
At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs. Alex Bedenkov, VP, Medical, International, AstraZeneca. SAVE YOUR SEAT!
Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly.
A recent Sermo survey indicated that nearly two-thirds of responders changed their perception of medications or treatment options based on information obtained on social media. HCPs are pressed for time, eager to keep up with scientific and clinical developments, skeptical about big pharma, and increasingly focused on outcomes and metrics.
Register for Impetus’ upcoming live webinar on August 24, 10-11 AM ET: A Fireside Chat with Kaitlin Anstett, Senior Medical Advisor at Theratechnologies. They will also dive into topics related to patient-centricity and digital technologies in Pharma, including how these can be used to support HCPs and patients during this challenging time.
How continuing medical education is critical to clinicians being able to do their jobs and make the best of a golden age of scientific discovery. In this era of grab-and-go learning, continuing medical education (CME) is being transformed by digital and AI technology, which tailors learning to meet individual HCP needs.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. Asking strategic questions leads to a better understanding of medical practices and habits.
Medical publications are often highly valued by doctors because they are essential to their professional practice and continuous education. The main source of new and up-to-date information on medical research, clinical trials, treatment recommendations, and developments in medicalscience is medical journals.
Acting as a go-between for pharma and physicians, medicalscience liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). As with many aspects of the medical world, they are now shifting online. A fresh approach.
Heavy patient loads, paperwork, research, presentations at medical meetings, and department/academic obligations make it tough to keep up with the literature, new therapies, and understanding of how community level and peers manage their patients. Medical Industry Blogging. Fun and Educational Medical Content.
Working closely with Medical Affairs (MA) leaders and their teams , we have been hearing about their ongoing evolution and digital transformation for years. Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past.
For the life sciences industry, there are questions about the technology’s accuracy, as well as concerns relating to ethics, privacy, and security. In commercial, issues related to Medical, Legal, and Regulatory (MLR) review compliance will need to be carefully managed as well.
Related: How AI and Innovation Are Reshaping Pharma Sales Training in 2025 Breaking Down Silos Between Teams Success in pharmaceutical sales training isnt just about individual performanceit depends on how well different teams work together.
Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product. What skills are necessary to become a pharma sales rep?
It's the secret sauce to thriving in the pharma industry. From cutting-edge training techniques that break the mold, to the latest industry trends making waves, and the career development hacks every pharma rep should know – we've got it all covered. Welcome to the world where sales training isn't just a formality.
In recent years, there has been an increased focus on real world evidence to advance medicalscience and improve patient quality of life. Data lags can extend the duration of diagnostic studies substantially, ultimately delaying patient access to life-saving medications.
According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1. Get stakeholder buy in on the “why”.
What is the role of a Medical Sales Liaison (MSL). An MSL is a medically specialized representative for pharmaceutical companies. By outlining the product specifications, advising, and educating, they act as a bridge between pharma companies and their clients. Highlight those aspects during the address.
MedicalScience Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. Secondary: These are those who will ultimately determine the lifecycle and success of advanced treatments, diagnostic tools, and medications.
Derek Choy The Fine-Tuning API (Application Programming Interface) in OpenAI now enables the creation of hyper-personalized content to support brand managers, customer experience professionals, sales teams, and medicalscience liaisons.
sales, medicalscience liaisons, etc.). Furthermore, all patients, and especially those who are most vulnerable to severe outcomes from the virus, may be less willing or able to travel to the doctor’s office for non-COVID-related medical concerns. Which patients are most vulnerable to severe outcomes from COVID-19?
Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medicalscience can achieve. The way medical progress is going in classifying diagnoses ever more precisely, it gets harder and harder to find the right people for meaningful engagement.
“To remain at the forefront of medical research, pharma needs a faster, more predictive way of testing molecules before they go into humans,” says Steve Arlington, global life sciences industry advisor leader at PwC. “It’s very disappointing.
As what Harvard Business Review calls “a tidal wave of resignations” continues — with the highest rates for those ages 30-45 — and, as many pandemic-induced changes continue to alter to the structure of businesses worldwide (including pharma sales and marketing organizations) — many of our basic assumptions, approaches, and priorities need to shift.
About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe. He is responsible for building the medical affairs function across Europe and providing strategic and scientific guidance. Previously, he spent more than 10 years at Roche in multiple positions within medical affairs.
Are you ready to explore the fascinating world of MedicalScience Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals.
Medical sales is increasingly becoming an area of interest for veterans transitioning to civilian careers. The issue that often arises for veterans is the lack of a strong professional network, required licenses for a job, and no clear pathway from the military to a mid-to-high-skill civilian job like medical sales.
In addition, EHRs can track specific outcomes in support of value-based payments as well as help reduce medical errors (e.g., In parallel, life sciences companies have become increasingly aware of the ability to harness EHR data to solve for numerous challenges both in the pre-approval and post-commercialization arenas.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content